At a glance

Drugs
Apomorphine (Primary)
;
Apomorphine (Primary)

Indications
Parkinson's disease

Focus
Pharmacokinetics; Registrational

Sponsors
Cynapsus Therapeutics

Most Recent Events

10 Dec 2015
According to a Cynapsus Therapeutics media release, results of this study are expected to be submitted to the U.S. FDA as part of a U.S. new drug application (NDA) submission, as well as to European regulatory authorities as part of a European submission.

10 Dec 2015
Status changed from planning to completed, according to a Cynapsus Therapeutics media release.